Exploring the comprehensive review of diagnostic methods of oral cancer: A global scenario
1 Shri Venkateshwara College of Pharmacy, Puducherry-605102, India.
2 Department of Pharmacology, Shri Venkateshwara College of Pharmacy, Puducherry-605102, India.
3 Department of Pharmacognosy, Shri Venkateshwara College of Pharmacy, Puducherry-605102, India.
4 Department of Pharmaceutics, Shri Venkateshwara College of Pharmacy, Puducherry-605102, India.
Review
World Journal of Biology Pharmacy and Health Sciences, 2023, 15(01), 043–048.
Article DOI: 10.30574/wjbphs.2023.15.1.0292
Publication history:
Received on 21 May 2023; revised on 01 July 2023; accepted on 04 July 2023
Abstract:
Oral cancer is one of the common cancers in the worldwide, with a delayed clinical detection and prognosis. There is no specific biomarkers for this kind of disease and also no expensive therapeutic alternative methods. It is two to three times more prevalent in men than women in most ethnic groups. It is a preventable disease, where smoking and alcohol-considered major risk factors. India has one of the highest incidences of oral cancer and delayed stage recovery is common. Surgery remains the treatment of choice and adjuvant treatment is recommended in patients with high-risk. Functional outcomes and treatment-related morbidity needs to be considered, and reconstruction with free tissue transfer provides the best outcomes. Particularly while speech, swallowing, mastication efficiency, and dental rehabilitation. Future generations has to fight these dreadful diseases until scientists and clinicians are provided the opportunities to expand efforts to prevent, detect (early), and eradicate oral and other head and neck cancers.
Keywords:
Oral Cancer; Dental rehabilitation; Dreadful diseases; Types of cancer
Full text article in PDF:
Copyright information:
Copyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0